Keros Therapeutics, Inc. (KROS): S-3 filed Sep 10, 2026

Form type

S-3

Filing date

Sep 10, 2026

Accession number

0001628280-26-061321

Filer

Keros Therapeutics, Inc. (CIK 1664710)